Functional HLA‐DM on the surface of B cells and immature dendritic cells

HLA‐DM (DM) plays a critical role in antigen presentation through major histocompatibility complex (MHC) class II molecules. DM functions as a molecular chaperone by keeping class II molecules competent for antigenic peptide loading and serves as an editor by favoring presentation of high‐stability peptides. Until now, DM has been thought to exert these activities only in late endosomal/lysosomal compartments of antigen‐presenting cells. Here we show that a subset of DM resides at the cell surface of B cells and immature dendritic cells. Surface DM engages in complexes with putatively empty class II molecules and controls presentation of those antigens that rely on loading on the cell surface or in early endosomal recycling compartments. For example, epitopes derived from myelin basic protein that are implicated in the autoimmune disease multiple sclerosis are down‐modulated by DM, but are presented in the absence of DM. Thus, this novel concept of functional DM on the surface may be relevant to both protective immune responses and autoimmunity.

[1]  Eric O Long,et al.  Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Marino Zerial,et al.  EEA1 links PI(3)K function to Rab5 regulation of endosome fusion , 1998, Nature.

[3]  S. Pierce,et al.  HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes. , 1996, Journal of immunology.

[4]  H. Geuze,et al.  Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments , 1991, Nature.

[5]  P. Cresswell,et al.  HLA-DM Interactions with Intermediates in HLA-DR Maturation and a Role for HLA-DM in Stabilizing Empty HLA-DR Molecules , 1996, The Journal of experimental medicine.

[6]  P. Chavrier,et al.  Different endocytic compartments are involved in the tight association of class II molecules with processed hen egg lysozyme and ribonuclease A in B cells. , 1995, Journal of cell science.

[7]  H. Horstmann,et al.  Intracellular transport and localization of major histocompatibility complex class II molecules and associated invariant chain , 1991, The Journal of cell biology.

[8]  R. Germain,et al.  Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments. , 1995, Immunity.

[9]  H. Kalbacher,et al.  Human monoclonal antibody with T-cell-like specificity recognizes MHC class I self-peptide presented by HLA-DR1 on activated cells. , 2008, Tissue antigens.

[10]  F. Brodsky,et al.  A Dominant-negative Clathrin Mutant Differentially Affects Trafficking of Molecules with Distinct Sorting Motifs in the Class II Major Histocompatibility Complex (MHC) Pathway , 1998, The Journal of cell biology.

[11]  B. Dobberstein,et al.  Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR. , 1995, Journal of immunology.

[12]  L. Lampson,et al.  Two populations of Ia-like molecules on a human B cell line. , 1980, Journal of immunology.

[13]  J. Neefjes,et al.  Direct vesicular transport of MHC class II molecules from lysosomal structures to the cell surface , 1996, The Journal of cell biology.

[14]  P. Cresswell,et al.  HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides , 1992, Nature.

[15]  J. Rohrer,et al.  The targeting of Lamp1 to lysosomes is dependent on the spacing of its cytoplasmic tail tyrosine sorting motif relative to the membrane , 1996, The Journal of cell biology.

[16]  M. Zerial,et al.  The diversity of Rab proteins in vesicle transport. , 1997, Current opinion in cell biology.

[17]  C. Melief,et al.  B lymphocytes secrete antigen-presenting vesicles , 1996, The Journal of experimental medicine.

[18]  Antonio Lanzavecchia,et al.  Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells , 1997, Nature.

[19]  E. Appella,et al.  Competition for antigen presentation in living cells involves exchange of peptides bound by class II MHC molecules , 1989, Nature.

[20]  D E Banks,et al.  Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire. , 1997, The Journal of clinical investigation.

[21]  Eric O Long,et al.  Antigen presentation mediated by recycling of surface HLA-DR molecules , 1995, Nature.

[22]  H. Ploegh,et al.  Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. , 1996, Immunity.

[23]  J. Monaco,et al.  New class ll-like genes in the murine MHC , 1991, Nature.

[24]  Eric O Long,et al.  Peptide loading onto recycling HLA‐DR molecules occurs in early endosomes , 1998, European journal of immunology.

[25]  S. Green,et al.  Kinetics of intracellular transport and sorting of lysosomal membrane and plasma membrane proteins , 1987, The Journal of cell biology.

[26]  D. Weber,et al.  DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. , 1995, Immunity.

[27]  H. Ploegh,et al.  How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. , 1995, Annual review of cell and developmental biology.

[28]  K. Mason,et al.  Short-lived complexes between myelin basic protein peptides and IAk. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[29]  L. Adorini,et al.  Antigen presentation of hen egg‐white lysozyme but not of ribonuclease A is augmented by the major histocompatibility complex class II‐associated invariant chain , 1991, European journal of immunology.

[30]  C. Watts,et al.  Characterization of transport of newly assembled, T cell-stimulatory MHC class II-peptide complexes from MHC class II compartments to the cell surface. , 1997, Journal of immunology.

[31]  G. Hämmerling,et al.  Identification of destabilizing residues in HLA class II‐selected bacteriophage display libraries edited by HLA‐DM , 1999, European journal of immunology.

[32]  P. Cresswell,et al.  Negative regulation by HLA-DO of MHC class II-restricted antigen processing. , 1997, Science.

[33]  J. Thomas August,et al.  Purification and characterization of human lysosomal membrane glycoproteins. , 1989, Archives of biochemistry and biophysics.

[34]  R. Germain,et al.  The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy , 1994, The Journal of experimental medicine.

[35]  A. Vogt,et al.  HLA-DM - an endosomal and lysosomal chaperone for the immune system. , 1999, Trends in biochemical sciences.

[36]  P. A. Peterson,et al.  Intracellular transport of class II MHC molecules directed by invariant chain , 1990, Nature.

[37]  D. Fremont,et al.  Crystal structure of mouse H2-M. , 1998, Immunity.

[38]  D. Wiley,et al.  Invariant chain made in Escherichia coli has an exposed N-terminal segment that blocks antigen binding to HLA-DR1 and a trimeric C-terminal segment that binds empty HLA-DR1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[39]  G. Hämmerling,et al.  Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[40]  G. Schuler,et al.  Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. , 1999, Journal of immunological methods.

[41]  C. Harding,et al.  Early endosomes and a late endocytic compartment generate different peptide-class II MHC complexes via distinct processing mechanisms. , 1997, Journal of immunology.

[42]  P. Cresswell,et al.  Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells. , 1994, Immunity.

[43]  K. Carlsson,et al.  HLA-DM is expressed on the cell surface and colocalizes with HLA-DR and invariant chain in human Langerhans cell , 1998, Archives of Dermatological Research.

[44]  D. Wraith,et al.  Affinity for class II MHC determines the extent to which soluble peptides tolerize autoreactive T cells in naive and primed adult mice--implications for autoimmunity. , 1995, International immunology.

[45]  P. A. Peterson,et al.  The MHC class II molecule H2-M is targeted to an endosomal compartment by a tyrosine-based targeting motif. , 1995, Immunity.

[46]  J. Strominger,et al.  Extracellular antigen processing and presentation by immature dendritic cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Trowsdale,et al.  Association between HLA-DM and HLA-DR in vivo. , 1996, Immunity.

[48]  O. Bakke,et al.  MHC class II-associated invariant chain contains a sorting signal for endosomal compartments , 1990, Cell.

[49]  J. Trowsdale,et al.  Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. , 1994, Science.

[50]  R. Doebele,et al.  Aberrant intermolecular disulfide bonding in a mutant HLA-DM molecule: implications for assembly, maturation, and function. , 1998, Journal of immunology.

[51]  M. Anderson,et al.  Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[52]  D. Zaller,et al.  The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation. , 1998, Immunity.

[53]  G. Hämmerling,et al.  Structural features of the invariant chain fragment CLIP controlling rapid release from HLA-DR molecules and inhibition of peptide binding. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[54]  A. Sette,et al.  A DR17‐restricted T cell epitope from a secreted Mycobacterium tuberculosis antigen only binds to DR17 molecules at neutral pH , 1997, European journal of immunology.

[55]  William S. Lane,et al.  Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size , 1992, Nature.

[56]  C. Benoist,et al.  Functionality of major histocompatibility complex class II molecules in mice doubly deficient for invariant chain and H-2M complexes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[57]  C. Watts,et al.  Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments , 1990, Nature.

[58]  A. Klippel,et al.  Evidence for phosphatidylinositol 3-kinase as a regulator of endocytosis via activation of Rab5. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[59]  D. Wraith,et al.  An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. , 1993, International immunology.

[60]  J. Bonifacino,et al.  A lysosomal targeting signal in the cytoplasmic tail of the beta chain directs HLA-DM to MHC class II compartments , 1995, The Journal of cell biology.

[61]  B. Evavold,et al.  Enhanced Dissociation of HLA-DR-Bound Peptides in the Presence of HLA-DM , 1996, Science.

[62]  D. Zaller,et al.  Mediation by HLA-DM of dissociation of peptides from HLA-DR , 1995, Nature.

[63]  John Trowsdale,et al.  A new human HLA class II-related locus, DM , 1991, Nature.

[64]  L. Santambrogio,et al.  Abundant empty class II MHC molecules on the surface of immature dendritic cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[65]  J. Bodmer,et al.  Production and characterization of monoclonal antibodies recognizing the alpha-chain subunits of human ia alloantigens. , 1983, Immunology.

[66]  G. Hämmerling,et al.  Editing of the HLA‐DR‐peptide repertoire by HLA‐DM. , 1996, The EMBO journal.

[67]  P. A. Peterson,et al.  Reconstitution of an operational MHC class II compartment in nonantigen-presenting cells. , 1994, Science.

[68]  Eric O Long,et al.  HLA‐DR‐restricted presentation of purified myelin basic protein is independent of intracellular processing , 1997, European journal of immunology.

[69]  P. Cresswell,et al.  HLA-DM induces clip dissociation from MHC class II αβ dimers and facilitates peptide loading , 1995, Cell.

[70]  C. Benoist,et al.  Mice Lacking H2-M Complexes, Enigmatic Elements of the MHC Class II Peptide-Loading Pathway , 1996, Cell.

[71]  M. Lotze,et al.  Rapid extracellular degradation of synthetic class I peptides by human dendritic cells. , 1998, Journal of immunology.

[72]  R. Mitchell,et al.  Detection of functional class II-associated antigen: role of a low density endosomal compartment in antigen processing , 1995, The Journal of experimental medicine.

[73]  M. Mattson,et al.  Short precursor shortens memory , 1997, Nature.

[74]  G. Hämmerling,et al.  How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest? , 1997, Immunology today.

[75]  N. Koch,et al.  Identification of a sequence that mediates promiscuous binding of invariant chain to MHC class II allotypes. , 1998, Journal of immunology.

[76]  G. Hämmerling,et al.  HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. , 1997, Immunity.

[77]  Partho Ghosh,et al.  The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3 , 1995, Nature.

[78]  Eric O Long,et al.  Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen. , 1994, Journal of immunology.

[79]  G. Hämmerling,et al.  Self-Release of CLIP in Peptide Loading of HLA-DR Molecules , 1995, Science.

[80]  H. Ruley,et al.  H2-M Mutant Mice Are Defective in the Peptide Loading of Class II Molecules, Antigen Presentation, and T Cell Repertoire Selection , 1996, Cell.

[81]  D. McFarlin,et al.  Immunological aspects of demyelinating diseases. , 1992, Annual review of immunology.

[82]  Antonio Lanzavecchia,et al.  Irreversible association of peptides with class II MHC molecules in living cells , 1992, Nature.